Direxion Daily S&P Biotech Bull 3X Shares (LABU): Trump News

LABU – Trump just slammed the drug industry at his press conference.


Key Facts Surrounding This News Item


  • LABU had a POWR Rating of C (Neutral) coming into today.
  • LABU was 18.64% above its 10-Day Moving Average coming into today.
  • LABU was 20.45% above its 20-Day Moving Average coming into today.
  • LABU was 14.37% above its 50-Day Moving Average coming into today.
  • LABU was 6.71% above its 100-Day Moving Average coming into today.
  • LABU was 15.94% above its 200-Day Moving Average coming into today.
  • LABU had returned +35.45% year-to-date leading up to today’s news, versus a +1.31% return from the benchmark S&P 500 during the same period.

More Info About Direxion Daily S&P Biotech Bull 3X Shares (LABU)


The investment objective of the Direxion Daily S&P Biotech Bull 3X ETF seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index. View our full LABU ticker page with ratings, news, and more.

LABU at a Glance

LABU Current POWR Rating™
Overall POWR Rating™
LABU Current Price $45.49 4.31%
More LABU Ratings, Data, and News

LABU Price Reaction

The day of this event (Jan. 11, 2017)
LABU Closing Price$37.90 10.63%
LABU Volume5,926,000
64.17% from avg
Leading up to this event
LABU 1-mo returnN/A%
After this event
LABU 1-day return6.61%
LABU 3-day return11.87%
LABU 5-day return10.85%

LABU Price Chart

More Direxion Daily S&P Biotech Bull 3X Shares (LABU) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All LABU News
Page generated in 0.8686 seconds.